CIBMTR Profile Banner
CIBMTR Profile
CIBMTR

@CIBMTR

Followers
6K
Following
3K
Statuses
3K

Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy.

Milwaukee, WI
Joined November 2011
Don't wanna be here? Send us removal request.
@CIBMTR
CIBMTR
1 day
JOB POSTING: CIBMTR and the Data Science Institute (DSI) at @MedicalCollege, are seeking a senior clinical informatician to jointly serve as CIBMTR Senior Scientific Director and as Associate Director of Clinical Informatics in the DSI. Learn more, here:
1
0
1
@CIBMTR
CIBMTR
2 days
#Tandem25 will highlight successful data automation strategies in healthcare during the IT and Informatics Track sessions. Find out more:
Tweet media one
0
0
0
@CIBMTR
CIBMTR
3 days
CIBMTR's February Newsletter is now available! Read a message from our Advisory Committee Chair, about our new Scientific Director, about one of our working committees, and hear about next week's #Tandem25 meetings! Read more online:
Tweet media one
0
0
1
@CIBMTR
CIBMTR
3 days
The @BMTCTN Track at #Tandem25 will cover barriers to clinical trials, mental health tips for researchers, and more:
Tweet media one
0
0
0
@CIBMTR
CIBMTR
5 days
@RahulBanerjeeMD @ASTCT Yes, this is correct! And the app is now available in your app store.
1
1
4
@CIBMTR
CIBMTR
5 days
The #Tandem25 Mobile App is now available for download in your device's app store! Visit either the Apple App Store or Google Play Store to download the app today! @ASTCT
Tweet media one
0
0
0
@CIBMTR
CIBMTR
10 days
Hear from the Scientific Organizing Committee Co-Chairs about what you can expect at #Tandem25. Learn more in Tandem Meetings News: @ASTCT
Tweet media one
0
1
2
@CIBMTR
CIBMTR
10 days
RT @JeffAuletta: Check out the 2025 @ASTCT @CIBMTR Tandem Meetings video and news page! Can't wait to see you next month in Hawaii! https…
0
4
0
@CIBMTR
CIBMTR
16 days
Barriers to access prevent patients with diverse racial and ethnic backgrounds from getting #BMT. However, fewer people from diverse backgrounds than white people are enrolled on clinical trials, according to a new @BMTCTN study:
Tweet media one
0
1
0
@CIBMTR
CIBMTR
23 days
RT @nmdp_org: Allogeneic transplants continue to be one of the best treatment options for blood cancers like AML, growing at a rate of 7-8%…
0
2
0
@CIBMTR
CIBMTR
24 days
RT @TheEBMT: In memory of Kristin Page (1974–2024) 🕊️ A beloved colleague whose warmth, dedication, and outstanding contributions were felt…
0
2
0
@CIBMTR
CIBMTR
1 month
Did you know that CIBMTR surveys patients' feelings and their quality of life? Learn more about CIBMTR's PRO data collection:
Tweet media one
0
0
0
@CIBMTR
CIBMTR
1 month
Choose the #Tandem25 registration option that works best for you. Attend sessions live in person or register for access to on-demand session recordings as soon as 3 hours after the live session takes place. Register today at:
Tweet media one
0
0
2
@CIBMTR
CIBMTR
1 month
A CIBMTR study looked at a CAR-T called axicabtagene ciloleucel, or axi-cel. In the study, 1,300 people got axi-cel during 2017-2020. Researchers observed patients for about 2 years after treatment. Read more:
Tweet media one
0
3
6
@CIBMTR
CIBMTR
1 month
Multiple myeloma is a blood cancer that is treated with #BMT and then with long-term medicines. According to a new @BMTCTN study, these treatments can cause side effects for years. Read more:
Tweet media one
0
0
0
@CIBMTR
CIBMTR
2 months
Thank you to everyone who visited CIBMTR’s booth and attended oral and poster abstract sessions during #ASH24! We look forward to seeing you Feb. 12-15, 2025, for #Tandem25!
Tweet media one
0
0
4
@CIBMTR
CIBMTR
2 months
RT @ASTCT: ASTCT & @CIBMTR are now accepting late-breaking abstracts to #Tandem25! Showcase your research to thousands of HCT, cell therapy…
0
1
0
@CIBMTR
CIBMTR
2 months
RT @Razan_Mohty: Dr. Heather Stefanski discussing finding a suitable donor for racially and ethnically diverse patients. #DEI @CIBMTR @Bet
0
8
0
@CIBMTR
CIBMTR
2 months
RT @kaggle: Competition Launch Alert! Equity in post-HCT Survival Predictions hosted by @CIBMTR and @nmdp_org 🎯 Challenge: Develop models…
0
3
0
@CIBMTR
CIBMTR
2 months
RT @ASTCT: ASTCT & @CIBMTR are now accepting late-breaking abstracts to #Tandem25! Showcase your research to thousands of HCT, cell therapy…
0
1
0